Physician
Infectious Disease
Dr. Gerald V. Quinnan Jr., MD
|
|
Give Review
Gerald V. Quinnan Jr., MD is an expert in the field of Infectious Disease. She went to medical school at Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67/57 in Research/PrimaryCare. She received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Gerald Quinnan is a published doctor as well. She has 100 publications published. The latest was: Letter: Rubella vaccination during pregnancy.
Publications
- Global Health and the U.S. Department of Defense: A Call for an Evidence Base.
- Probing the HIV GP120 envelope glycoprotein conformation by NMR.
- Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.
- Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.
- Malaria diagnosis and hospitalization trends, Brazil.
- Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a...
- Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization.
- High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru.
- Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reac...
- Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T...
- Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
- Use of polymerase chain reaction technique to confirm VecTest screening results in Plasmodium falciparum and Plasmodium vivax VK 210 laboratory-infected Anopheles step...
- Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1.
- A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing ant...
- Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expressio...
- Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41...
- A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associ...
- Regulatory concerns regarding AIDS vaccine development.
- Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.
- Molecular epidemiology of Plasmodium vivax in the State of Amazonas, Brazil.
- Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.
- Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity a...
- Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.
- Ototoxicity of erythromycin.
- Relative importance of viruses and bacteria in the etiology of pediatric diarrhea in Taiwan.
- Cytotoxic T lymphocyte response to murine cytomegalovirus infection.
- The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.
- Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique.
- Prostatic carcinoma presenting as pericardial tamponade.
- Letter: Rubella vaccination during pregnancy.
- Variable infections with and serologic responses of rabbits to five different HIV-1 strains, including one neural tissue isolate.
- High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
- Licensing of allergen patch tests.
- FDA's Center for Biologics Evaluation and Research comments on the Report of the expert panel.
- Lack of evidence for HIV-2 infection among at-risk individuals in Brazil.
- Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose.
- Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.
- Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans.
- International collaborative study to compare assays for antibodies that neutralize human immunodeficiency virus.
- Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.
- Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion.
- Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
- Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.
- Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.
- Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
- A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).
- An analysis of serum samples positive for HTLV-III antibodies.
- Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine.
- Efficacy of inactivated influenza vaccine delivered by oral administration.
- Risks and benefits of vaccinia-vectored vaccine from the regulatory perspective.
- Relation of chronic disease and immune response to influenza vaccine in the elderly.
- Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy.
- Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation.
- Epstein-Barr virus in the bone marrow of patients with aplastic anemia.
- Antibodies to simian immunodeficiency virus in African green monkeys in Africa in 1957-62.
- Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
- Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response t...
- Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome.
- Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome.
- Interleukin 2 therapy in infectious diseases: rationale and prospects.
- Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma.
- More on partitioning and inactivation of AIDS virus in immune globulin preparations.
- Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.
- Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation.
- Biological characterization of human interleukin-2 mutant proteins. Structure-activity relationship studies.
- Issues in the evaluation of AIDS vaccines.
- Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.
- Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus.
- Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influen...
- Comparison of live and inactivated influenza vaccine in high risk children.
- Immunization of elderly people with high doses of influenza vaccine.
- Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. A prospective study.
- Association of influenza immunization with reduction in mortality in an elderly population. A prospective study.
- Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cells.
- Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and ...
- Longitudinal serologic evaluation of an infant with acquired immunodeficiency syndrome.
- Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.
- Immunization of elderly people with two doses of influenza vaccine.
- The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.
- Influenza vaccine and pneumonia mortality in a nursing home population.
- Public Health Service study of Reye's syndrome and medications. Report of the main study.
- Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome.
- Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
- Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.
- Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
- Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome.
- Role of interferon in AIDS.
- Prevention of herpes simplex virus diseases in man.
- Regulatory issues with 'new technology' interferon.
- Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: localization in T cells.
- Large granular lymphocytes provide an accessory function in the in vitro development of influenza A virus-specific cytotoxic T cells.
- Role of cytotoxic T lymphocytes in murine cytomegalovirus infection.
- Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.
- Cell-mediated immunity in cytomegalovirus infections--a review.
- HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.
- Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.
- Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infec...
- Involvement of natural killer cells in the pathogenesis of murine cytomegalovirus interstitial pneumonitis and the immune response to infection.
- Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test.
Schools
Saint Louis University School of Medicine
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Boston University Medical Center -
Saint Louis University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Dmitri Iarikov, MD |
|
|
Dr. Puran P. Mathur, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter D. Crompton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth M. Jacobs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Moore Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rakesh Makadia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jude R. Alexander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard E. Josefberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natasha P. Haag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Passi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Sauri, MD
This Doctor is OpenDoctor Recommended.
|